tirzepatide heart failure trial 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality vs sitagliptin, but offered no Positive heart failure trial results!

10.1080/000164800750044443 59 HuB

A $15/month NAC supplement will do more for GLP-1 skin than a $200 skincare routine

They require very specific environments to grow before they can be considered therapeutic (ready to be used for treatment)

Studies requiring gene expression data, biopsy analysis, inflammatory biomarkers, or multi-tissue effects require GHK-Cus broader biological range

The girls at the front were so sweet and nice and Dr Caplan provided a thorough assessment and individualized the treatment for me

We prioritize your safety by ensuring that any treatment planwhether it involves a single medication or a combinationis appropriate for your specific needs